4.7 Article

Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy

Journal

CLINICAL CANCER RESEARCH
Volume 16, Issue 19, Pages 4695-4701

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-10-0356

Keywords

-

Categories

Funding

  1. NIH, National Cancer Institute, Center for Cancer Research

Ask authors/readers for more resources

Wnt ligands are lipid-modified secreted glycoproteins that regulate embryonic development, cell fate specification, and the homeostasis of self-renewing adult tissues. In addition to its well-established role in thymocyte development, recent studies have indicated that Wnt/beta-catenin signaling is critical for the differentiation, polarization, and survival of mature T lymphocytes. Here, we describe our current understanding of Wnt signaling in the biology of post-thymic T cells, and discuss how harnessing the Wnt/beta-catenin pathway might improve the efficacy of vaccines, T-cell-based therapies, and allogeneic stem cell transplantation for the treatment of patients with cancer. Clin Cancer Res; 16( 19); 4695-701. (C) 2010 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available